NCT05102604 (AvoSkin) is a NA clinical trial of Avocado in Skin Inflammation, sponsored by University of California, Los Angeles.

Who is sponsoring NCT05102604?

NCT05102604 is sponsored by University of California, Los Angeles.

What drugs are being tested in NCT05102604?

Interventions in NCT05102604: Avocado, Habitual diet.

What condition does NCT05102604 study?

NCT05102604 studies Skin Inflammation.

Is NCT05102604 still recruiting?

NCT05102604 is currently completed. Last updated 1 November 2021.

Last reviewed 2021-11-01 · How we verify

NCT05102604: AvoSkin

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Avocado vs. Usual Diet on Skin Aging

Completed NA Last updated 1 November 2021

What this trial tests

NA trial testing Avocado in Skin Inflammation in 40 participants. Completed in 30 December 2020.

Timeline

1 January 2020

Primary endpoint
30 December 2020

30 December 2020

Quick facts

Lead sponsor	University of California, Los Angeles
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	40
Start date	1 January 2020
Primary completion	30 December 2020
Estimated completion	30 December 2020
Sites	1 location across United States

Drugs / interventions tested

Avocado
Habitual diet

Conditions studied

Skin Inflammation — all drugs for Skin Inflammation →

Sponsor

University of California, Los Angeles

Who can join

Adults 25 to 90, female only, with Skin Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to assess the effect of providing one avocado per day on skin health in comparison with a control group maintaining their habitual diets. Participants will be randomly assigned to one of two equally sized groups. Both groups will be instructed to continue to follow their habitual diet but the intervention group will receive one avocado per day. Participants will be followed for outcomes for a four-month period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Avocado Consumption Increased Skin Elasticity and Firmness in Women - A Pilot Study.
Henning SM, Guzman JB, Thames G, Yang J, et al · · 2022 · cited 14× · PMID 35037373 · DOI 10.1111/jocd.14717

Verify or expand the search:

Other trials of Avocado

Trials testing the same drug.

NCT06208085 — Avocado Consumption, Nutrients in Human Milk, and Infant Cognitive Development · NA · recruiting
NCT05958368 — Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes · NA · recruiting
NCT05263011 — Avocado Snacks in a Prediabetic Population · NA · completed
NCT05009420 — Validation of Avocatin b as a Biomarker of Food Intake · NA · completed

Other recruiting trials for Skin Inflammation

Currently open trials in the same condition.

NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT06750653 — Skin Barrier Function and Inflammation in Aging: The BIA Study · Phase 4 · recruiting
NCT05535738 — Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation · Phase 2, PHASE3 · recruiting

Other University of California, Los Angeles trials

Trials by the same sponsor.

NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05102604 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
Last refreshed: 1 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05102604.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing